Abstract: Systems for providing scanning within distributed services are provided herein. In some embodiments, a system includes a plurality of segmented environments that each includes an enforcement point that has an active probe device, and a plurality of workloads that each implements at least one service. The system also has a data center server coupled with the plurality of segmented environments over a network. The data center server has a security controller configured to provide a security policy to each of the plurality of segmented environments and an active probe controller configured to cause the active probe device of the plurality of segmented environments to execute a scan.

Abstract: Systems for providing scanning within distributed services are provided herein. In some embodiments, a system includes a plurality of segmented environments that each includes an enforcement point that has an active probe device, and a plurality of workloads that each implements at least one service. The system also has a data center server coupled with the plurality of segmented environments over a network. The data center server has a security controller configured to provide a security policy to each of the plurality of segmented environments and an active probe controller configured to cause the active probe device of the plurality of segmented environments to execute a scan.

Abstract: A health monitoring system which can collect data generated from multiple health, fitness, and environmental data generating devices by a health application running on a portable smart device, or a computing device that is connected to a wireless Bluetooth Network using Secure Simple Pairing. The generated data is collected by the health application that identifies the device and selectively connects, so that data transfer can be authenticated and securely transmitted.

Abstract: Systems for providing vulnerability scanning within distributed microservices are provided herein. In some embodiments, a system includes a plurality of microsegmented environments that each includes a hypervisor, an enforcement point that has an active probe device, and a plurality of virtual machines that each implements at least one microservice. The system also has a cloud data center server coupled with the plurality of microsegmented environments over a network. The cloud data center server has a security controller configured to provide a security policy to each of the plurality of microsegmented environments and an active probe controller configured to cause the active probe device of the plurality of microsegmented environments to execute a vulnerability scan.

Abstract: Methods of determining a subject's ototoxicity risk from administration of a pharmacotherapeutic compound having an ototoxicity risk, methods of administering a pharmacotherapeutic compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays, and addressable collections for performing embodiments of the methods are provided herein.

Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of ototoxicity in response to receiving one or more platinum-coordinating compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of ototoxicity.

Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of cardiotoxicity in response to receiving one or more anthracycline compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of cardiotoxicity.

Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of cardiotoxicity in response to receiving one or more anthracycline compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of cardiotoxicity.

Abstract: Methods of determining a subjects ototoxicity risk from administration of platinum-coordinating compounds having an ototoxicity risk, methods of administering a platinum-coordinating compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays and addressable collections for performing embodiments of the methods are provided herein.

Abstract: The present invention provides for a Line of Sight (LOS) electromagnetic beam (EM) detection system configured with an enclosure, a detection device, a processing device, a storage device, and a communication device. The enclosure may or may not be electromagnetically shielded from the surrounding environment. The enclosure may contain one or more detection devices and one or more portals configured for a user to look through. The detection devices may be a non-contacting, active-dry electroencephalogram (EEG) electrode or a high input impedance EEG electrode. The processing device may be a specifically programmed general purpose computer. The communication device may be auditory and/or visual. The storage device may store signals from the detection device for later analysis and statistical manipulation. In some embodiments, the LOS detection system may be used as a switch responding to interaction with a LOS beam emanating from an ocular cavity.

Abstract: An apparatus and method for characterizing electrical signals from a living organism comprising sensors configured to be positioned to receive the electrical signals emanating from a human signal source. A processor may be configured to interpret readings made by the sensors to output a characterization of the electrical signals.

Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of ototoxicity in response to receiving one or more platinum-coordinating compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of ototoxicity.

Abstract: The present invention provides for a Line of Sight (LOS) electromagnetic beam (EM) detection system configured with an enclosure, a detection device, a processing device, a storage device, and a communication device. The enclosure may or may not be electromagnetically shielded from the surrounding environment. The enclosure may contain one or more detection devices and one or more portals configured for a user to look through. The detection devices may be a non-contacting, active-dry electroencephalogram (EEG) electrode or a high input impedance EEG electrode. The processing device may be a specifically programmed general purpose computer. The communication device may be auditory and/or visual. The storage device may store signals from the detection device for later analysis and statistical manipulation. In some embodiments, the LOS detection system may be used as a switch responding to interaction with a LOS beam emanating from an ocular cavity.

Abstract: A method of displaying information for learning purposes comprises the steps of providing within a computer an information set having at least a first information topic. The first information topic includes a plurality of discrete information elements. The discrete information elements are caused to be arranged for display within the computer in a sequence selected from a plurality of predetermined sequences. The discrete information elements are displayed with a display operably associated with the computer in the selected sequence.